Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

The perception of apathy by caregivers of patients with dementia in Parkinson's disease.

Camargo CHF, Serpa RA, Matnei T, Sabatini JS, Teive HAG.

Dement Neuropsychol. 2016 Oct-Dec;10(4):339-343. doi: 10.1590/s1980-5764-2016dn1004014.

2.

Altered Functional Brain Connectomes between Sporadic and Familial Parkinson's Patients.

Tang Y, Xiao X, Xie H, Wan CM, Meng L, Liu ZH, Liao WH, Tang BS, Guo JF.

Front Neuroanat. 2017 Nov 6;11:99. doi: 10.3389/fnana.2017.00099. eCollection 2017.

3.

Gait and Cognition in Parkinson's Disease: Cognitive Impairment Is Inadequately Reflected by Gait Performance during Dual Task.

Gaßner H, Marxreiter F, Steib S, Kohl Z, Schlachetzki JCM, Adler W, Eskofier BM, Pfeifer K, Winkler J, Klucken J.

Front Neurol. 2017 Oct 26;8:550. doi: 10.3389/fneur.2017.00550. eCollection 2017.

4.

Accumulation of 123I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson's Disease.

Murakami H, Nohara T, Uchiyama M, Owan Y, Futamura A, Shiromaru A, Tsukada S, Saito Y, Kuroda T, Yano S, Ishigaki S, Katoh H, Munechika J, Ohgiya Y, Gokan T, Ono K.

Front Aging Neurosci. 2017 Sep 29;9:321. doi: 10.3389/fnagi.2017.00321. eCollection 2017.

5.

Affective Correlates of Psychosis in Parkinson's Disease.

Factor SA, Scullin MK, Freeman A, Bliwise DL, McDonald WM, Goldstein FC.

Mov Disord Clin Pract. 2017 Mar-Apr;4(2):225-230. doi: 10.1002/mdc3.12381. Epub 2016 Jun 16.

PMID:
28944257
6.

General Anesthesia versus Local Anesthesia in StereotaXY (GALAXY) for Parkinson's disease: study protocol for a randomized controlled trial.

Holewijn RA, Verbaan D, de Bie RMA, Schuurman PR.

Trials. 2017 Sep 7;18(1):417. doi: 10.1186/s13063-017-2136-8.

7.

Insular atrophy at the prodromal stage of dementia with Lewy bodies: a VBM DARTEL study.

Roquet D, Noblet V, Anthony P, Philippi N, Demuynck C, Cretin B, Martin-Hunyadi C, Loureiro de Sousa P, Blanc F.

Sci Rep. 2017 Aug 25;7(1):9437. doi: 10.1038/s41598-017-08667-7.

8.

Dual-Task Performance in GBA Parkinson's Disease.

Srulijes K, Brockmann K, Ogbamicael S, Hobert MA, Hauser AK, Schulte C, Fritzen J, Schwenk M, Gasser T, Berg D, Maetzler W.

Parkinsons Dis. 2017;2017:8582740. doi: 10.1155/2017/8582740. Epub 2017 Jul 27.

9.

Analyzing the effectiveness of vocal features in early telediagnosis of Parkinson's disease.

Erdogdu Sakar B, Serbes G, Sakar CO.

PLoS One. 2017 Aug 9;12(8):e0182428. doi: 10.1371/journal.pone.0182428. eCollection 2017.

10.

Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson's disease.

Lin CH, Chaudhuri KR, Fan JY, Ko CI, Rizos A, Chang CW, Lin HI, Wu YR.

Sci Rep. 2017 Jul 24;7(1):6306. doi: 10.1038/s41598-017-06782-z.

11.

FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.

Meles SK, Vadasz D, Renken RJ, Sittig-Wiegand E, Mayer G, Depboylu C, Reetz K, Overeem S, Pijpers A, Reesink FE, van Laar T, Heinen L, Teune LK, Höffken H, Luster M, Kesper K, Adriaanse SM, Booij J, Leenders KL, Oertel WH.

Mov Disord. 2017 Oct;32(10):1482-1486. doi: 10.1002/mds.27094. Epub 2017 Jul 22.

12.

Towards Mobile Gait Analysis: Concurrent Validity and Test-Retest Reliability of an Inertial Measurement System for the Assessment of Spatio-Temporal Gait Parameters.

Kluge F, Gaßner H, Hannink J, Pasluosta C, Klucken J, Eskofier BM.

Sensors (Basel). 2017 Jun 28;17(7). pii: E1522. doi: 10.3390/s17071522.

13.
14.

Caregiver burden is increased in Parkinson's disease with mild cognitive impairment (PD-MCI).

Jones AJ, Kuijer RG, Livingston L, Myall D, Horne K, MacAskill M, Pitcher T, Barrett PT, Anderson TJ, Dalrymple-Alford JC.

Transl Neurodegener. 2017 Jun 19;6:17. doi: 10.1186/s40035-017-0085-5. eCollection 2017.

15.

A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease.

Hayete B, Wuest D, Laramie J, McDonagh P, Church B, Eberly S, Lang A, Marek K, Runge K, Shoulson I, Singleton A, Tanner C, Khalil I, Verma A, Ravina B.

PLoS One. 2017 Jun 12;12(6):e0178982. doi: 10.1371/journal.pone.0178982. eCollection 2017.

16.

Open-Label Fosmetpantotenate, a Phosphopantothenate Replacement Therapy in a Single Patient with Atypical PKAN.

Christou YP, Tanteles GA, Kkolou E, Ormiston A, Konstantopoulos K, Beconi M, Marshall RD, Plotkin H, Kleopa KA.

Case Rep Neurol Med. 2017;2017:3247034. doi: 10.1155/2017/3247034. Epub 2017 Apr 16.

17.

Cortical Potentials Prior to Movement in Parkinson's Disease.

Patil AL, Sood SK, Goyal V, Kochhar KP.

J Clin Diagn Res. 2017 Mar;11(3):CC13-CC16. doi: 10.7860/JCDR/2017/25520.9598. Epub 2017 Mar 1.

18.

Autonomic and electrocardiographic findings in Parkinson's disease.

Gibbons CH, Simon DK, Huang M, Tilley B, Aminoff MJ, Bainbridge JL, Brodsky M, Freeman R, Goudreau J, Hamill RW, Luo ST, Singer C, Videnovic A, Bodis-Wollner I, Wong PS; NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators.

Auton Neurosci. 2017 Jul;205:93-98. doi: 10.1016/j.autneu.2017.04.002. Epub 2017 Apr 14.

PMID:
28506500
19.

Glutathione as a Redox Biomarker in Mitochondrial Disease-Implications for Therapy.

Enns GM, Cowan TM.

J Clin Med. 2017 May 3;6(5). pii: E50. doi: 10.3390/jcm6050050. Review.

20.

Imaging genetics approach to Parkinson's disease and its correlation with clinical score.

Kim M, Kim J, Lee SH, Park H.

Sci Rep. 2017 Apr 21;7:46700. doi: 10.1038/srep46700.

Supplemental Content

Support Center